Umbilical Cords and Placentas Treating HIV, Cerebral Palsy, Cancers, and More
Order My KitWhat can stem cells from the umbilical cord, tissue, and placenta be used to treat?
Patients can request the release of stem cells from an umbilical cord blood bank like Anja Health to a physician overseeing the treatment. Treatment occurs via an IV of the entire bag of cord blood stem cells or localized injections.
Cord blood, tissue, and placenta stem cells can be used to:
- Improve motor skills in children with cerebral palsy
- Reverse Type 1 Diabetes
- Promote protective effects on hair loss
- Show promise as heart failure treatment
- Significantly improve symptoms of Crohn's disease, an inflammatory bowel syndrome
- Used to treat neurological and immune disorders (placenta, specifically)
- Treating acne scars (placenta, specifically)
- Treating leukemia
- Promote CAR T-cell therapy, which is an immunotherapy that fights cancer
- Immune cell therapy
How we maximize stem cell count
We use manual processing to process our stem cells. Manual processing is handled in the lab by trained technicians rather than a machine. Manual processing is utilized by Anja Health because in the case that very minimal samples are collected (i.e. <40 mL of cord blood), the lab technicians can customize procedures as needed in order to maximize stem cell preservation.
Clinical Trials by Therapeutic Category
58% (598) of all current clinical trials are in oncology, including leukemia, lymphoma, and cancers of the brain, breast, bladder, cervix, colon, esophagus, ovaries, pancreas, and others.
7% (67) are in cardiovascular disorders, including congestive heart failure, myocardial infarction, critical limb ischemia, heart disease, and others.
6% (58) are in musculoskeletal disorders, including spinal muscular atrophy, osteoarthritis, muscular dystrophies, cartilage defects, and bone fractures and disorders, and others.
Neurological & Other Disorders
- Cartilage–Hair Hypoplasia
- Günther Disease (Congenital Erythropoietic Porphyria)
- Hermansky–Pudlak Syndrome
- Pearson’s Syndrome
- Shwachman–Diamond Syndrome
- Systemic Mastocytosis
- Adrenoleukodystrophy (ALD) / Adrenomyeloneuropathy (AMN)
- Krabbe Disease (Globoid Cell Leukodystrophy)
- Metachromatic Leukodystrophy
- Pelizaeus–Merzbacher Disease
- Gaucher Disease
- Niemann–Pick Disease
- Sandhoff Disease
- Wolman Disease
- Lesch–Nyhan Syndrome
Lymphomas & Leukemias
- Hodgkin’s Lymphoma
- Neuroblastoma
- Medulloblastoma
- Retinoblastoma
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Juvenile Chronic Myelogenous
- Leukemia (JCML)
- Juvenile Myelomonocytic Leukemia (JMML)
- Refractory Anemia (RA)
- Refractory Anemia with Ringed Sideroblasts (RARS)
- Refractory Anemia with Excess Blasts (RAEB)
- Refractory Anemia with Excess Blasts in Transformation (RAEB-T)
- Chronic Myelomonocytic Leukemia (CMML)
Immune Disorders
- Epstein–Barr Virus Susceptibility
- SCID with Adenosine Deaminase Deficiency (ADA-SCID)
- SCID which is X-linked
- SCID with absence of T & B Cells
- SCID with absence of T Cells, Normal
- B CellsOmenn Syndrome
- Kostmann Syndrome
- Ataxia–Telangiectasia
- Bare Lymphocyte Syndrome
- Common Variable Immunodeficiency
- DiGeorge Syndrome
- Leukocyte Adhesion Deficiency
- Lymphoproliferative Disorders (LPD)
- Wiskott–Aldrich Syndrome
Metabolic & Genetic Disorders
- Chediak–Higashi Syndrome
- Neutrophil Actin Deficiency
- Reticular Dysgenesis
- Mucopolysaccharidoses (MPS)
- Hurler’s Syndrome (MPS–IH)
- Scheie Syndrome (MPS–IS)
- Hunter’s Syndrome (MPS–II)
- Sanfilippo Syndrome (MPS–III)
- Morquio Syndrome (MPS–IV)
- Maroteaux–Lamy Syndrome (MPS–VI)
- Sly Syndrome, Beta–Glucuronidase Deficiency (MPS–VII)
- Mucolipidosis II (I–cell Disease)
Blood Disorders & Anemia
- Aplastic Anemia
- Congenital Dyserythropoietic Anemia
- Fanconi Anemia
- Sickle Cell Disease
- Beta Thalassemia Major (Cooley’s Anemia)
- Blackfan-Diamond Anemia
- Pure Red Cell Aplasia
- Myeloproliferative Disorders
- Acute Myelofibrosis
- Agnogenic Myeloid Metaplasia (Myelofibrosis)
- Polycythemia Vera
- Essential Thrombocythemia
What happens if I don't bank cord blood,cord tissue, or the placenta?
You will have to use a random donor's cord blood. The chances of survival are much higher if your donor is a relative - especially if you are the donor yourself
A donor's hematopoietic stem cells could be rejected, which could be fatal. Being related to the donor or being the donor yourself increases chances of survival.
On top of that, using a donor's stem cells are exorbitantly more expensive than banking umbilical cord blood.
Finding a donor can be expensive
Using a donor's stem cells are exorbitantly more expensive than banking umbilical cord blood.
If you're a person of color or mixed race, your chances of finding a donor might be slim
Saving your own stem cells gives you access whenever you may need them. A patient's probability of finding a matching bone marrow donor or cord blood unit on the Be The Match Registry® varies, ranging from 29% to 79% based on their ethnic background.
Stem cells can potentially be useful for your whole family.
Saving your own baby's stem cells guarantees at least a partial match for family members.
Some diseases can be treated using the baby's own cord blood (allogeneic use) since they are 100% match! Biological family members can benefit as well.
Data shows that in the next 18 years, 1 in 16 children may need stem cells to better their quality of life.
This information was gained by adding figures from childhood incidence of diseases and extrapolation based on the 18-year figure (multiplying some annual figures by 18 to reach the number). The chart below shows the amount of children by disease in 18 years.
| Diseases | Numbers in 1 year | Numbers in 18 years * |
|---|---|---|
Cancer | 3,500 children | 63,000 children |
Leukemia | 353,000 children currently | 116,000 children |
Aplastic Anemia | 216 children | 3,900 children |
Diamond-Blackfan Anemia | 35 children | More than 600 children |
Fanconi Anemia | 20 children | 360 children |
Sickle Cell Disease | Affects 1 out of every 500 African-American and 1 in every 1,000 Hispanic newborns | 21,945 (African-American), 17,991 (Hispanic) |
Langerhans Cell Histiocytosis | 8 children | 144 children |
SCID | 100 children | 1800 children |
Wiskott-Aldrich Syndrome | 10 per million males | 367 children |
Krabbe Disease | 1 in 100,000 people | 738 children |
Hurler Syndrome | 1 in every 100,000 babies born | 738 children |
Metachromatic Leukodystrophy | 1 in 40,000 individuals | 1,845 children |
Sanfilippo Syndrome | 1 in 70,000 births | 1,054 children |
How much does Anja Health cost?
Receive your kit in the mail within 5 business days or less!
Chat with our team
We are quick. Like, really quick.
